chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a nurse referring to an unknown number of patients of unknown age and gender. On unknown dates the patients were vaccinated with doses of improperly stored RECOMBIVAX HB (strength, does, lot# and route not provided) (incorrect product storage). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
SEVERE PAIN ON LEFT  ARM FOR 2 DAYS AND DIZZINES.PATIENT IS A REFUGE AND WE REFERED TO CHATOLIC CHARITIS TO  BE SEEN BY A PHYSICIAN.WE HAVE DIFICULTY COMUNICATING WITH PATIENT BECAUSE OF LANGUAGE BARRIOR.
Really tired 24 hrs later or less on & off through today.  Noted palpitations, tightness in chest about 5 hrs after vaccination intermittent til now.  Welts on back & shoulders 3/20, 6 AM until MN.  Has had light intermittent wheezing, ongoing.  Hoarseness noted til now.  Also notes nausea.
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients. In approximately 2015 (reported as since 13-MAR-2015), the patients were vaccinated with doses of oral, ROTATEQ lot # K010221, K011663, K016313 and lot # reported as K015816 (expiration dates, dose, route and site of administrations were not reported) that were exposed to temperatures outside of the recommended range. No adverse effects had been observed or reported. Follow up information has been received from the reporting healthcare professional on 02-JUL-2015, who informed that a patient was vaccinated on 08-JUN-2015 with a dose of oral, ROTATEQ LOT # K016313, expiration date not reported, (administration route was not provided). According to the reporter the vaccine dose that was administered underwent a temperature exucrsion for 87 hours. This is one of several reports from the same reporter. Additional information has been requested.
Extreme itching at the site of her vitiligo; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Extreme itching at the site of her vitiligo) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     Concurrent medical conditions included Vitiligo.    On 07-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PRURITUS (Extreme itching at the site of her vitiligo). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK dosage form. At the time of the report, PRURITUS (Extreme itching at the site of her vitiligo) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.
Mother informed nurse of the day that son was unable to walk and cried when he tried to do so. There was no fever,redness or swelling.
Mother signed consent for Moderna vaccine to be administered to a 17 year old.  Spoke to patient and no adverse S/E experienced
Presented 3 days afterward to an emergency room with nausea/jaw pain and elevated troponin.
Patient reported that she developed a rash and itching on 10/21/22 and started Benadryl at bedtime that night and took a second dose the morning of 10/22/22. After several minutes of discussion she stated she was having "some" difficulty breathing but not specific on symptoms. I recommended a trip to urgent care or the ER. I was unable to reach her or leave a message on 10/22/22. I did speak to her on 10/23/22 and she stated that she had gone to the ER and was told to let if run it's course and all she needed was Benadryl, but on treatment for the breathing. She plans to follow up with her doctor on 10/24/22.
Pharmacist (myself) reporting that Patient used a different last name and fancified personal information to get an extra dose of Moderna bivalent vaccine. could not find patient vaccination history on VAIRS so tried to look up with  just the first 2 letters of first name. Record found on VAIR verified patient identity and vaccine history. Patient had stated that she is in need of a second dose of covid vaccine and has no insurance and no id on her, where as this was actually her 6th dose.
Fever; chills, body ache; weak; arm soreness; lower back pain; headache.
Local reactions, red, warm, tender area about 3cm X 5cm. No wheezing, resp. distress or systemic symptoms. Onset within 1 day.
pt recv vax 18JUN96 & 19JUN96 pt exp nausea & soreness & swelling @ inj site where there was a knot the size of a quarter;
hallucinate/ saw people running for 2 days; This case was reported by a pharmacist and described the occurrence of hallucination in a 78-year-old female patient who received Herpes zoster (Shingrix) (batch number 394KF, expiry date 23rd September 2022) for prophylaxis.   On 7th January 2021, the patient received the 1st dose of Shingrix. On 7th January 2021, less than a day after receiving Shingrix, the patient experienced hallucination (serious criteria GSK medically significant). On an unknown date, the outcome of the hallucination was recovered/resolved.   It was unknown if the reporter considered the hallucination to be related to Shingrix.  Additional details were provided as follows: After receiving Shingrix, the patient got hallucination that she saw people running for 2 days. The reporter consented to follow up.
WCC with vaccines 12/21/12 - pt. woke over night w/temp 103. Given ibuprofen, slept ok. 12/22 in the morning, temp 102. Spit up ibuprofen. Seen in office by dr. Pt evaluated. Dad reassured - not forwarded to dt w/dads concerns. Dr rec that pt still receive vaccines as benefit outweighs risk of fever. Hep B was only new vaccine component received.
Patient reported chest pain/stabbing pain on her left side/side of injection shortly after receiving dose. Reported sweating. Patient remained in area for additional time, drank water and felt better. This was a booster dose after the J&J vaccine.
A few hours after receiving the vaccine the patient felt dizzy. It subsided and the patient fell asleep. Upon waking up it was much worse and resulted in the patient almost falling down the stairs.
Patient reported feeling faint and nauseous. Placed on monitor, oxygen saturation was normal. Rapid Response Team called. Patient reported feeling that tongue was swollen. RRT escorted patient to Emergency Room.
I have had swelling in my lymph nodes above the right collar bone near the neck.  The size is approximately 2 - 2.5 inches.
I felt tired and had a slight headache.  The next day, I felt more tired; headache; felt un-well with slight achy feeling.; felt un-well with slight achy feeling.; next day I was extremely exhausted with stuffy; with stuffy nose with no drainage; I was extremely tired/weak; problem was diarrhea; This is a spontaneous report from a contactable Consumer.   A 66-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: unknown) via an unspecified route of administration, administered in right arm on 29Jul2021 11:00 Am (at the age of 66-years), as dose 1, single for covid-19 immunization. Patient known allergies includes mefoxin. The patient relevant medical history includes cancer in remission and fibromyalgia. The patient concomitant medications includes lexapro, vitamin D-3 and prolia on two week. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that the next day after to shot, the patient felt tired and had a slight headache. The next day, the patient felt more tired and just felt unwell with slight achy feeling. The next day the patient  was extremely exhausted with stuffy nose with no drainage and upon slight physical exertion (specifically walking up stairs) she was extremely tired/weak and had to sit down with breathlessness that improved with rest but reoccurred throughout the day with slight exertion. A more troublesome problem was diarrhea that started at 2 am two days after the shot and continued for two more days. This diarrhea occurred after every time she ate something and was uncontrollable. Finally the third day after taking an over the counter antidiarrheal drug the constant diarrhea stopped and extreme fatigue was improving each day. The patient had no treatment for adverse event. The patient did not had vaccination prior to covid and  also did not tested for covid post vaccination. The outcome of the events was recovering.   No Follow-up attempts are possible. No information is expected further.
Immediately felt dizzy and left side of body (leg, arm and face) went numb, then became super relaxed (had to remind myself to breathe), husband had to help me upstairs to bed. Cold chills during the night. Next day very dizzy and light headed, arm still numb and fatigue in evening. Following day work up normal but felt dizzy and lightheaded if moved around too much.  One week later (today) feel very dizzy and light headed.
Information has been received from a consumer concerning her 15 year old son with no medical history or allergies who in May of 1999 was vaccinated subcutaneously with a 0.5 ml dose of varicella virus vaccine live. There was no concomitant medication. On 9/25/2005 the patient experienced a breakthrough case of chickenpox. Unspecified medical attention was sought and no diagnostic or laboratory test were performed. The patients breakthrough case of chickenpox persisted. No product quality complaint was involved. No further information was provided. Additional information is not expected.
Student noticed pink flare 10-18mm x 40mm on left arm at site of Yellow Fever vaccination. Went back to clinic on 5/3 to show nurse. Denied pain, discomfort. Afebrile. Not raised, just pink.
On 11/8/00 at 02:00, pt moaning with abdominal pain. On 11/9/00 at 01:00, pt moaning with increased temperature to 99 (ax), wheezing, restless and at 03:30 started coughing. SpO2 90%. Given Tylenol and Robitussin. At 21:40, pt moaning, wheezing in lower lobes. V/S 76/41, 114, 48, 97.4F (ax); SpO2 78%. Transferred by ambulance to hospital. Of the 21 individuals receiving immunizations 11/3/00, there were only 2 on prednisone that had sudden respiratory distress on the 6th day, post vax.  Follow up received on 4/24/01 states the pt passed away on 2/7/01. Cause of Death - pneumonia.
Arm was immediately sore, with soreness continuing for 2 days.  3 days after injection, a large (3" diameter) red circle formed immediately adjacent to injection site. Area was hot to touch, swollen, and itchy. No treatment given. Symptoms are beginning to dissipate on their own 3 days after red circle first appeared.
Red, warm, very painful injection site. Erythema 3.5 cm diameter, induration.
MD reported pt devel GBS w/painful paresthesias of hands & feet 2wk p/vax;
Headache, Diarrhea, INJECTION SITE PAIN Narrative: employee states about 15 minutes after injection headache began, later in the day she experienced injection site pain, and that evening diarrhea. Symptoms continued and increased intensity the next day. The following symptoms subsided except for some residual diarrhes
Pt received the second dose of Pfizer BioNTech Covid 19 Vaccine (exp. 8/2021) at 1132. At 1202, patient reported swelling and tingling on right cheek. Patient denied itchiness, rashes, hives, and difficulty breathing/swallowing/talking. Patient reported similar reaction to penicillin, no current medications and a heart murmur since she was a child. EMT assessed patient vital: blood pressure 140/60 mmHg, heart rate 106 bpm, and SpO2 98%. Patient given water. Patient tolerated drinking water. Patient offered oral diphenhydramine. Lead Nurse administered 2 doses of 25 mg/10 ml oral diphenhydramine at 1209. At 1214, vitals reassessed: blood pressure (unable to obtain due to unreliable blood pressure cuff, heart rate 98 bpm, SpO2 97%, and patient reported decreased swelling. At 1228, vitals reassessed: blood pressure (unable to obtain due to unreliable blood pressure cuff, heart rate 94 bpm, SpO2 98%, and patient reported decreased swelling. At 1233, patient reassessed. Patient reported swelling and tingling on right cheek "went away". Lead nurse educated patient on signs/symptoms of when to seek emergency care, to see an allergist, follow up with primary care provider about reaction to vaccine, and how to sign up on v-safe. Patient left facility with husband at 1235. Patient left facility with unlabored respirations and steady gait.
MIGRAINE; FEVER; This spontaneous report received from a patient via a company representative concerned a 53 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included Psoriasis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination.  Non-company suspect drugs included: adalimumab (solution for injection in pre-filled pen, subcutaneous, batch number was not reported) 40 mg, frequency was not reported, from 10-JAN-2021 for psoriasis.  No concomitant medications were reported.  On APR-2021, the subject experienced migraine. On APR-2021, the subject experienced fever.  Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 103 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and dose of adalimumab was not changed. The patient was recovering from migraine, and the outcome of fever was not reported. This report was non-serious.
Severe body and muscles aches in both arms, shoulders, arms, back, hips and legs.  Could not lift either arm above head. Skin was extremely sensitive to cold and touch.  Heat and OTC pain reliever helped.  Symptoms had improved within 24 hours but not fully.  Some aches persist.  I tested positive for Covid-19 in October 2020 and although my symptoms were very mild when I had the virus, my long lasting symptoms still persist (numbness and tingling in both arms, taste and smell come and go, fatigue continues, phantom smells of cigarette smoke, etc).  I have also heard that symptoms can be worse for those that have had Covid before the vaccine.
Hives began within 24 hours of vaccine and persisted more than 3 days. She returned for discussion of the "rash" and was treated with BENADRYL by mouth.
Info has been received from a physician concerning her daughter who was vaccinated with a dose of MMRII at 12 months old. Subsequently, 2 weeks after vaccination, the pt developed a rash. She was noted to have recovered. No fever was noted. It was also noted that the pt was vaccinated with a dose of varicella virus vaccine live and developed a rash. Additional info has been requested.
12:15 c/o red, raised rash with hives right forearm, small red area left arm, 4pm back of right hand red rash, per mom saw Dr pm 10/26/06, spoke to mom 10/27/06 reports Dr above symptoms were related to a local reaction from something other the FluMist, rash gone next day after Benadryl, Child in school.
ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/17/2023 CARDIOMYOPATHY, UNSPECIFIED CARDIOGENIC SHOCK 1/17/2023 CARDIOMYOPATHY, UNSPECIFIED
One day post vax pt developed 8 inch diameter red, hot, itchy, swollen area. Four days post vax pt still had a 3 inch diameter red, hot , itchy, swollen area and was advised to see family physician. Reaction was on the right arm where Menomune was administered. Pt had no reaction on the left arm where Hepatitis A vax was administered.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOTENSION ANGIOEDEMA, INIT
Feel like have the flu; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient after vaccination felt like had the flu. The patient asked is this common felt like flu.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient. A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25Mar2021 as dose 1, single (Lot number: ER8732), in left arm and on 15Apr2021 as dose 2, single (Lot number: ER8729) at the age of 45 years, in left arm for Covid-19 immunisation; CoviD-19 vaccine miRNA (miRNA 1273) (MODERNA COVID-19 VACCINE), on 01Nov2021 as dose 3 (booster), single (Lot number: 076C21A), in left arm for Covid-19 immunisation. The patient's relevant medical history included: "Known allergies: sulfa drugs" (unspecified if ongoing); "Vaccine dose number=2,1 Pfizer, Vaccine dose number=3 Moderna" (unspecified if ongoing), notes: Vaccine dose number=2,1 Pfizer, Vaccine dose number=3 Moderna. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant) with onset 13May2022, outcome "unknown", COVID-19 (medically significant) with onset 13May2022, outcome "not recovered" and all described as "13May2022- first positive test". The patient underwent the following laboratory tests and procedures: Rheumatoid factor: (12May2022) Negative, notes: first day of symptoms but negative RA test; SARS-CoV-2 test: (13May2022) positive, notes: first positive test. Therapeutic measures were taken as a result of vaccination failure, Covid-19. Anti-viral details product-COVID-19 Treatment, brand-Paxlovid, treatment start date-15May2022, treatment stop date-18May2022, indication-Treatment of COVID-19.Adverse event: 12May - first day of symptoms but negative RA test (while in withheld, withheld; COVID contracted while in the withheld) 13May - first positive test 15May - began Paxlovid 18May - stopped Paxlovid (after 3 days due to side effects) 19May -24May - felt 100% better 24May - tested positive with RA test, though the line was very faint 25May, late afternoon - symptoms returned, nasally stuffiness, post nasal drip causing throat irritation, and feeling run down. no fever, no other symptoms. 26May am- took another RA test, very bold test line appeared quickly. Symptoms are slightly worse than yesterday. Adverse events start date: 25May2022 start time: 11:00 AM. If patient recovered: Recovering If treatment AE: No. No follow-up attempts are needed. No further information is expected.
Patient received second dose of Moderna COVID-19 vaccine on 5/11/2021, which was 15 days after the initial dose was administered on 4/26/2021. The vaccinator, RN, notified a nursing vaccine supervisor, , RN, of this error.  RN, informed the other vaccine supervisors including , RN of this error. Because the patient was vaccinated prior to the 28 day window, she was not eligible for the second dose at time of administration. Per CDC guidelines, the patient was informed that she would not need an additional vaccination even though this was administered too soon. Patient verbalized understanding.
Child was coughing, fussy, wheezing, shakey parent took her to the ER.  Triaged at 2316, Vitals were stable.  O2 sats 98%.  No interventions were provided during the visit, observation of status only.  Physician recommended to defer further doses of the H1N1 vaccine due to likely reaction.  Pt. was discharged from ER at 00:23.
5NOV 230PM pt recv vax;w/in 10sec post vax pt stiffening, back arching, extremely pale, unresponsive called 911-placed on back-opened airway, determined resp status;BP 80/40, P83 started responding by 60sec;MD felt pt fainted;urine incont
Presented with recent history of falls with acute mental status change (confusion, hallucinations) - found to be COVID+. SpO2 92% RA, placed on 2L NC. BP 116/69, HR 100, RR 20. AKI (pk SCr 2.1) Treated with dexamethasone (stopped early due to clinical improvement and delirium), remdesivir, tocilizumab and intermediate enoxaparin dosing. Anticoagulation complicated by epistaxis. Renal function improve with increased PO intake. Discharged home with home services.
Headache, Myalgia, Arthralgia, Fever, chills, fatigue, injection site pain Narrative: Employee reported injection site pain on arm, as well as fever (101 F), chills, joint pain, muscle pain/body aches, and fatigue. Reports took ibuprofen (unknown dose/frequency).
Rash is back and is on throat; rash is back and is above breast; chest broke out (bumpy); Arm was red and puffy and traveled down arm (like when get bee sting and you can see venom going down arm); arm got red; arm pain; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (arm pain), ERYTHEMA (arm got red), DISCOMFORT (Arm was red and puffy and traveled down arm (like when get bee sting and you can see venom going down arm)), RASH (Rash is back and is on throat) and RASH (rash is back and is above breast) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history was provided.).    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 07-Mar-2021, the patient experienced ERYTHEMA (arm got red). On 12-Mar-2021, the patient experienced DISCOMFORT (Arm was red and puffy and traveled down arm (like when get bee sting and you can see venom going down arm)) and RASH (chest broke out (bumpy)). On 31-Mar-2021, the patient experienced RASH (Rash is back and is on throat) and RASH (rash is back and is above breast). At the time of the report, PAIN IN EXTREMITY (arm pain), ERYTHEMA (arm got red), DISCOMFORT (Arm was red and puffy and traveled down arm (like when get bee sting and you can see venom going down arm)), RASH (Rash is back and is on throat), RASH (rash is back and is above breast) and RASH (chest broke out (bumpy)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided for the events.
Experiencing injection site (left deltoid) soreness; Muscle soreness with movement; Overal minor discomfort; This is a spontaneous report from a contactable consumer (the patient). A 43-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not reported) via an unspecified route of administration in left deltoid on 03Feb2021 at single dose for COVID-19 immunization. No relevant medical history. The patient's concomitant medications were not reported. The patient experienced injection site (left deltoid) soreness, muscle soreness with movement, and overall minor discomfort in 2021. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Within seconds of administration Left full arm redness/significant swelling/ warm to touch extending to the full length and circumference of the arm, throat scratching. Administered Zantac/Benedryl/Ibuprofen/?steroids immediately and continued for 4-5 days. Swelling improved over the course of the week, leaving several large hematomas to the L arm from all of the swelling for several weeks to follow.
Flushing - feeling of warmth, anxiety. Received water. BP 144/61 (pulse 89), 160/78 (pulse 82).